ASN: Elderly with chronic kidney disease benefit from SGLT2 inhibitors
Coverage from Medical Daily, MedCentral, and pharmaphorum details findings on SGLT2 inhibitors at ASN Kidney Week 2026.
10 trends tracked about this subject — the full history, oldest to newest below.
Coverage from Medical Daily, MedCentral, and pharmaphorum details findings on SGLT2 inhibitors at ASN Kidney Week 2026.
A modeling study of 193 countries estimates that replacing regular salt with potassium-enriched salt could prevent nearly 3 million deaths a year from cardiovascular and kidney disease.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A ten-year study links fruit and vegetable consumption to reduced hospitalizations for kidney patients.
Recent studies and public commentary highlight the potential health benefits of continuous glucose monitoring devices.
New data indicates that the risk of heart failure, kidney disease, or death reaches 55% within ten years following a type 2 diabetes diagnosis.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
A kidney drug already used by some patients may now offer hope to millions more with non-diabetic kidney disease